Core Viewpoint - Expand Energy (EXE) is expected to report a significant increase in quarterly earnings and revenues, indicating strong business performance and positive market sentiment [1]. Earnings and Revenue Estimates - Analysts forecast quarterly earnings of $1.88 per share, reflecting a year-over-year increase of 241.8% [1]. - Anticipated revenues are projected to reach $2.25 billion, showing a 40.9% increase compared to the same quarter last year [1]. - The consensus EPS estimate has been revised 2.8% higher over the last 30 days, indicating a positive reevaluation by analysts [2]. Production Metrics - Analysts project 'Total Daily Production - Oil' to reach 16.72 thousand barrels per day, up from 12.00 thousand barrels per day year-over-year [5]. - The average prediction for 'Total Daily Production - NGL' is 83.74 thousand barrels per day, slightly down from 85.00 thousand barrels per day year-over-year [5]. - The 'Total Daily Production' estimate is currently under review, with comparisons to last year's figures pending [7]. Pricing Metrics - The 'Average Sales Price - NGL' is expected to be $23 per barrel, down from $27 per barrel year-over-year [6]. - Analysts estimate the 'Average Sales Price - Oil' to be $49 per barrel, compared to $60 per barrel in the previous year [6]. Market Performance - Over the past month, shares of Expand Energy have returned +1.9%, contrasting with the Zacks S&P 500 composite's -0.3% change [7]. - Currently, EXE holds a Zacks Rank 3 (Hold), suggesting its performance may align with the overall market in the near future [7].

Analysts on Wall Street project that Palo Alto Networks (PANW) will announce quarterly earnings of $0.93 per share in its forthcoming report, representing an increase of 14.8% year over year. Revenues are projected to reach $2.58 billion, increasing 14.3% from the same quarter last year.The consensus EPS estimate for the quarter has undergone a downward revision of 1.4% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial ...

Wall Street analysts forecast that Suncor Energy (SU) will report quarterly earnings of $0.77 per share in its upcoming release, pointing to a year-over-year decline of 13.5%. It is anticipated that revenues will amount to $8.48 billion, exhibiting a decrease of 5.1% compared to the year-ago quarter.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 0.8% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projec ...

Core Insights - Novo Nordisk's stock closed at $50.29, reflecting a daily increase of 2.53%, outperforming the S&P 500's gain of 0.21% [1] - Over the past month, shares have decreased by 2.41%, underperforming both the Medical sector's increase of 3.7% and the S&P 500's gain of 0.89% [1] Earnings Projections - The upcoming earnings release is expected to show earnings of $0.9 per share, indicating a year-over-year decline of 1.1% [2] - Revenue is projected at $12.11 billion, representing a 1.19% decrease from the same quarter last year [2] Full Year Estimates - For the full year, analysts expect earnings of $3.57 per share and revenue of $47.87 billion, marking increases of 8.84% and 13.72% respectively from the previous year [3] - Recent changes in analyst estimates suggest a positive outlook on business and profitability [3] Zacks Rank and Performance - The Zacks Rank system, which assesses stock performance based on estimate changes, currently ranks Novo Nordisk at 5 (Strong Sell) [5] - The Zacks Consensus EPS estimate has decreased by 0.22% in the past month [5] Valuation Metrics - Novo Nordisk has a Forward P/E ratio of 13.74, which aligns with the industry average [6] - The Large Cap Pharmaceuticals industry, part of the Medical sector, holds a Zacks Industry Rank of 183, placing it in the bottom 26% of over 250 industries [6] Industry Insights - The Zacks Industry Rank evaluates the strength of industry groups based on the average Zacks Rank of individual stocks, with top-rated industries outperforming lower-rated ones by a factor of 2 to 1 [7]

Core Insights - Descartes Systems (DSGX) is expected to report quarterly earnings of $0.46 per share, reflecting a 9.5% increase year-over-year, with revenues forecasted at $182.56 million, an 8.2% increase from the previous year [1] Earnings Estimates - Changes in earnings estimates are crucial for predicting investor reactions to stock performance, with empirical studies showing a strong correlation between earnings estimate revisions and short-term stock price performance [2] - Analysts have maintained the consensus EPS estimate for the quarter over the past 30 days, indicating a reassessment of projections [1] Revenue Projections - Analysts project 'Revenues- Services' to reach $167.08 million, indicating an 11.6% year-over-year increase [4] - 'Revenues- License' is forecasted at $2.78 million, reflecting a 19.6% decrease from the same quarter last year [4] - The average prediction for 'Revenues- Professional services and other' is $13.10 million, showing a 16.2% decline year-over-year [4] Stock Performance - Shares of Descartes Systems have decreased by 8.4% over the past month, contrasting with a 0.4% increase in the Zacks S&P 500 composite [5] - The company holds a Zacks Rank of 3 (Hold), suggesting it is expected to perform in line with the overall market in the near future [5]

Core Viewpoint - FS KKR Capital (FSK) is expected to report a quarterly earnings per share (EPS) of $0.57, reflecting a 23% decline year-over-year, with revenues projected at $376.07 million, a decrease of 14.7% compared to the previous year [1]. Earnings Estimates - The consensus EPS estimate has been revised upward by 0.4% in the last 30 days, indicating a reassessment by analysts [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock performance [3]. Key Metrics Forecast - Analysts predict 'Investment income- Fee income' to be $9.82 million, down 53.2% year-over-year [5]. - The estimate for 'Investment income- Dividend and other income' is $74.61 million, indicating a 16.6% increase from the previous year [5]. - 'Investment income- Paid-in-kind interest income' is expected to reach $49.79 million, reflecting a 24.6% decline year-over-year [5]. - 'Investment income- Interest income' is forecasted at $239.33 million, down 17.5% from the prior-year quarter [6]. Stock Performance - Over the past month, FS KKR Capital shares have returned -1.6%, while the Zacks S&P 500 composite has increased by 2.1% [6]. - Currently, FS KKR Capital holds a Zacks Rank 4 (Sell), suggesting potential underperformance relative to the overall market in the near future [6].

Core Viewpoint - Analysts forecast Abbott (ABT) to report quarterly earnings of $1.30 per share, reflecting a year-over-year increase of 7.4%, with anticipated revenues of $11.41 billion, marking a 7.3% increase compared to the previous year [1]. Earnings Estimates - The consensus EPS estimate has been adjusted downward by 0.1% over the past 30 days, indicating a reassessment by covering analysts [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock performance [3]. Key Metrics Projections - Analysts estimate 'Net sales- Nutrition' to reach $2.20 billion, a year-over-year change of +6.3% [5]. - 'Net sales- Medical Devices- Diabetes Care' is projected at $2.04 billion, indicating an increase of +18.2% year over year [5]. - 'Net sales- Diagnostics' is expected to be $2.31 billion, reflecting a decrease of -4.4% from the previous year [5]. - 'Net sales- Established Pharmaceuticals' is estimated at $1.53 billion, showing a +9% change year over year [6]. - 'Net sales- Diagnostics- U.S.' is projected at $909.57 million, indicating a decline of -11.9% from the prior year [6]. - 'Geographic Revenue- U.S.' is expected to be $4.38 billion, with a year-over-year change of +4.3% [6]. - 'Geographic Revenue- International' is estimated at $7.02 billion, reflecting a +9.2% change year over year [7]. - 'Net sales- Nutrition- International' is projected to reach $1.23 billion, indicating a +9.8% change [7]. - 'Net sales- Nutrition- U.S.' is expected at $966.71 million, reflecting a +1.8% change [7]. - 'Net sales- Diagnostics- International' is forecasted at $1.40 billion, indicating a +1.3% change [8]. - 'Net sales- Medical Devices- Rhythm Management- U.S.' is projected at $325.63 million, reflecting a +13.1% change year over year [8]. - 'Net sales- Medical Devices- Rhythm Management- International' is expected to reach $339.38 million, indicating a +9.8% change year over year [9]. Stock Performance - Abbott shares have returned +0.5% over the past month, compared to the Zacks S&P 500 composite's +3.5% change, with a Zacks Rank 3 (Hold), suggesting that ABT is expected to mirror the overall market performance in the near future [9].

Core Viewpoint - Diamondback Energy (FANG) is expected to report a significant decline in quarterly earnings per share while experiencing a notable increase in revenues compared to the previous year [1]. Earnings Estimates - Wall Street analysts predict quarterly earnings of $2.63 per share, reflecting a decline of 41.8% year-over-year [1]. - The consensus EPS estimate has been adjusted upward by 6.8% over the past 30 days, indicating a reassessment of projections by analysts [2]. Revenue Projections - Total revenues are forecasted to be $3.37 billion, representing a year-over-year increase of 35.8% [1]. - Analysts estimate revenues from oil, natural gas, and natural gas liquids to reach $3.21 billion, indicating a change of +47.8% from the prior-year quarter [5]. - Oil sales revenues are projected at $2.73 billion, suggesting a +36.7% year-over-year change [5]. - Revenues from natural gas liquid sales are expected to reach $320.12 million, reflecting an increase of +87.2% year-over-year [5]. - Natural gas sales revenues are predicted to be $115.33 million, indicating a substantial year-over-year change of +2206.6% [6]. Production Metrics - Average daily production is expected to be 890,056 barrels of oil equivalent per day, up from 474,670 barrels in the same quarter last year [6]. - Total production volume is projected at 80,985 thousand barrels of oil equivalent, compared to 43,195 thousand barrels in the same quarter of the previous year [7]. - Total production volume for oil is estimated at 44,921 thousand barrels, up from 25,129 thousand barrels year-over-year [8]. - Total production volume for natural gas liquids is expected to be 18,364 thousand barrels, compared to 9,514 thousand barrels in the same quarter last year [9]. Price Estimates - Average prices for natural gas liquids are projected to be $18 per barrel, consistent with the previous year's figure [7][9]. - Average prices for oil are expected to reach $63 per barrel, down from $80 per barrel in the same quarter last year [10]. - Average prices for hedged natural gas liquids are estimated at $18 per barrel, unchanged from the previous year [7]. Market Performance - Diamondback shares have shown a return of +6.4% over the past month, outperforming the Zacks S&P 500 composite's +2.7% change [11].

Core Viewpoint - SS&C Technologies (SSNC) is expected to report quarterly earnings of $1.39 per share, reflecting a year-over-year increase of 9.5%, with revenues projected at $1.52 billion, a 4.5% increase compared to the previous year [1]. Earnings Estimates - The consensus EPS estimate for the quarter has remained unchanged over the last 30 days, indicating stability in analysts' projections [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock performance [3]. Key Metrics Forecast - Analysts forecast 'Adjusted Revenues- Software-enabled services' to reach $1.27 billion, indicating a year-over-year change of +6.3% [5]. - The consensus estimate for 'Revenues- License, maintenance and related' is $264.85 million, reflecting a year-over-year change of +2.2% [5]. - 'Adjusted Revenues- License, maintenance and related' is expected to be $252.69 million, showing a decline of -2.5% from the prior-year quarter [5]. Stock Performance - Over the past month, SS&C Technologies shares have recorded returns of +5%, compared to the Zacks S&P 500 composite's +5.4% change, suggesting performance alignment with the overall market [6].

Core Insights - Phreesia (PHR) is expected to report a quarterly loss of $0.13 per share, marking a 62.9% increase in losses compared to the same period last year [1] - Revenue forecasts for Phreesia stand at $114.69 million, reflecting a year-over-year increase of 13.3% [1] - The consensus EPS estimate has remained unchanged over the past 30 days, indicating stability in analysts' projections [1] Revenue Estimates - Analysts predict 'Revenue - Subscription and related services' will reach $52.43 million, a 12.2% increase from the previous year [4] - 'Revenue - Network solutions' is estimated at $33.40 million, showing a year-over-year change of 21.8% [4] - 'Revenue - Payment processing fees' is forecasted to be $28.87 million, indicating a 6.7% increase from the year-ago quarter [4] Client Metrics - The estimated 'Average healthcare services Clients' is projected at 4,373, up from 4,065 in the same quarter last year [5] - 'Average revenue per healthcare services client' is expected to reach $18.65 million, compared to $18.24 million a year ago [5] Payment Volume - 'Patient payment volume' is anticipated to be $1.25 billion, an increase from $1.17 billion in the previous year [6] Stock Performance - Phreesia shares have decreased by 2.8% over the past month, contrasting with the Zacks S&P 500 composite's increase of 8.2% [6] - The company holds a Zacks Rank 3 (Hold), suggesting it is expected to closely follow overall market performance in the near term [6]